Hulsebos TJ - Search Results

1

Mechanism of spreading of the highly related neurofibromatosis type 1 (NF1) pseudogenes on chromosomes 2, 14 and 22.

Luijten M, Wang Y, Smith BT, Westerveld A, Smink LJ, Dunham I, Roe BA, Hulsebos TJ. Luijten M, et al. Among authors: hulsebos tj. Eur J Hum Genet. 2000 Mar;8(3):209-14. doi: 10.1038/sj.ejhg.5200434. Eur J Hum Genet. 2000. PMID: 10780787

2

Assignment of the beta B1 crystallin gene (CRYBB1) to human chromosome 22 and mouse chromosome 5.

Hulsebos TJ, Gilbert DJ, Delattre O, Smink LJ, Dunham I, Westerveld A, Thomas G, Jenkins NA, Copeland NG. Hulsebos TJ, et al. Genomics. 1995 Oct 10;29(3):712-8. doi: 10.1006/geno.1995.9947. Genomics. 1995. PMID: 8575764

3

Identification and characterization of NF1-related loci on human chromosomes 22, 14 and 2.

Hulsebos TJ, Bijleveld EH, Riegman PH, Smink LJ, Dunham I. Hulsebos TJ, et al. Hum Genet. 1996 Jul;98(1):7-11. doi: 10.1007/s004390050151. Hum Genet. 1996. PMID: 8682511

4

Microsatellite instability and promoter methylation as possible causes of NF1 gene inactivation in neurofibromas.

Luijten M, Redeker S, van Noesel MM, Troost D, Westerveld A, Hulsebos TJ. Luijten M, et al. Among authors: hulsebos tj. Eur J Hum Genet. 2000 Dec;8(12):939-45. doi: 10.1038/sj.ejhg.5200565. Eur J Hum Genet. 2000. PMID: 11175282

5

Duplication and transposition of the NF1 pseudogene regions on chromosomes 2, 14, and 22.

Luijten M, Redeker S, Minoshima S, Shimizu N, Westerveld A, Hulsebos TJ. Luijten M, et al. Among authors: hulsebos tj. Hum Genet. 2001 Jul;109(1):109-16. doi: 10.1007/s004390100543. Hum Genet. 2001. PMID: 11479742

6

New distal marker closely linked to the fragile X locus.

Hulsebos TJ, Oostra BA, Broersen S, Smits A, van Oost BA, Westerveld A. Hulsebos TJ, et al. Hum Genet. 1991 Jul;87(3):369-72. doi: 10.1007/BF00200922. Hum Genet. 1991. PMID: 1677926 Free article.

7

Direct assignment of the human beta B2 and beta B3 crystallin genes to 22q11.2----q12: markers for neurofibromatosis 2.

Hulsebos TJ, Bijlsma EK, Geurts van Kessel AH, Brakenhoff RH, Westerveld A. Hulsebos TJ, et al. Cytogenet Cell Genet. 1991;56(3-4):171-5. doi: 10.1159/000133080. Cytogenet Cell Genet. 1991. PMID: 2055112

8

Regional fine mapping of the beta crystallin genes on chromosome 22 excludes these genes as physically linked markers for neurofibromatosis type 2.

Bijlsma EK, Delattre O, Juyn JA, Melot T, Westerveld A, Dumanski JP, Thomas G, Hulsebos TJ. Bijlsma EK, et al. Among authors: hulsebos tj. Genes Chromosomes Cancer. 1993 Oct;8(2):112-8. doi: 10.1002/gcc.2870080208. Genes Chromosomes Cancer. 1993. PMID: 7504514

9

Analysis of mutations in the SCH gene in schwannomas.

Bijlsma EK, Merel P, Bosch DA, Westerveld A, Delattre O, Thomas G, Hulsebos TJ. Bijlsma EK, et al. Among authors: hulsebos tj. Genes Chromosomes Cancer. 1994 Sep;11(1):7-14. doi: 10.1002/gcc.2870110103. Genes Chromosomes Cancer. 1994. PMID: 7529050

10

Family with neurofibromatosis type 2 and autosomal dominant hearing loss: identification of carriers of the mutated NF2 gene.

Bijlsma EK, Merel P, Fleury P, van Asperen CJ, Westerveld A, Delattre O, Thomas G, Hulsebos TJ. Bijlsma EK, et al. Among authors: hulsebos tj. Hum Genet. 1995 Jul;96(1):1-5. doi: 10.1007/BF00214177. Hum Genet. 1995. PMID: 7607639

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

87 results

Search Page